Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

28
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
28
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interventions to improve adherence among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis.

European journal of preventive cardiology·2026
Same author

Targeting excessive cholesterol deposition alleviates secondary lymphoedema.

Nature·2026
Same author

HDL metabolism and function in diabetes mellitus.

Nature reviews. Endocrinology·2025
Same author

Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction.

Antioxidants (Basel, Switzerland)·2024
Same author

Effect of insulin insufficiency on ultrastructure and function in skeletal muscle.

Journal of cachexia, sarcopenia and muscle·2023
Same author

ApoA-I Protects Pancreatic β-Cells From Cholesterol-Induced Mitochondrial Damage and Restores Their Ability to Secrete Insulin.

Arteriosclerosis, thrombosis, and vascular biology·2023
Same journal

Financial Toxicity: Inequities and Impact on Cardiovascular Disease.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Extracellular Mitochondria Mediate Endothelial Injury After Traumatic Brain Injury.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Sleep, Neural Circulatory Control, and Cardiovascular Disease: A Mechanistic Review.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Macrophage-Mediated Mechanisms of Vascular Remodeling in Arteriovenous Malformations.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Neutrophils Exhibit Delayed Spontaneous Apoptosis and Resistance to Regulatory T-Cell-Induced Apoptosis in Patients With Chronic Coronary Syndrome: Brief Report.

Arteriosclerosis, thrombosis, and vascular biology·2026
See all related articles

Related Experiment Video

Updated: Jul 25, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

319

ApoA-I and Diabetes.

Thomas W King1, Blake J Cochran1, Kerry-Anne Rye1

  • 1Faculty of Medicine and Health, School of Biomedical Sciences, University of New South Wales Sydney, Australia.

Arteriosclerosis, Thrombosis, and Vascular Biology
|June 29, 2023
PubMed
Summary
This summary is machine-generated.

Apolipoprotein A-I (ApoA-I) shows promise in treating diabetes by enhancing insulin sensitivity and pancreatic beta-cell function. Small peptides mimicking ApoA-I may offer new therapeutic options for diabetes management.

Keywords:
apolipoproteinscell survivalglucoseinsulininsulin resistance

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.6K

Related Experiment Videos

Last Updated: Jul 25, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

319
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.6K

Area of Science:

  • Biochemistry
  • Endocrinology
  • Metabolic Diseases

Background:

  • Apolipoprotein A-I (ApoA-I) is the primary apolipoprotein in high-density lipoprotein (HDL) and possesses cardioprotective functions.
  • Emerging evidence highlights significant antidiabetic properties of ApoA-I.

Purpose of the Study:

  • To review the antidiabetic functions of ApoA-I and their underlying mechanisms.
  • To evaluate the therapeutic potential of ApoA-I-mimicking peptides for diabetes treatment.

Main Methods:

  • Literature review of studies on ApoA-I's role in glucose metabolism and insulin signaling.
  • Analysis of research on ApoA-I's effects on pancreatic beta-cell function and survival.
  • Evaluation of preclinical and clinical data on ApoA-I-based therapies.

Main Results:

  • ApoA-I improves glycemic control by enhancing insulin sensitivity.
  • ApoA-I promotes pancreatic beta-cell survival and function, boosting insulin production and secretion.
  • Small peptides can replicate the antidiabetic effects of full-length ApoA-I.

Conclusions:

  • Increasing circulating ApoA-I levels may benefit patients with suboptimal glycemic control.
  • ApoA-I-mimicking peptides represent a promising avenue for innovative diabetes therapies.